Sure it does. It allows him to take sole control of the company. Not that that would change the ultimate demise of Musclepharm, but he could try and turn things around without the burden of public company rules and regulations.
It's inevitable. Musclepharm missed their opportunity a few years ago. Falling sales, deteriorating market, misguided vision, and zero investor interest.
News 
Market Data 
Discover 
